Search Results 531-540 of 24219 for In situ
This study will test whether immune functions in individual cancer patients can be characterized in ... in situ cervical cancer. Has known active central nervous ...
Exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical ...
No evidence of prior malignancy except adequately treated nonmelanoma skin cancer, in situ cervical carcinoma or any surgically- or radiation-cured ...
... in Carboplatin Combination ... Any malignancy within past 5-years, except non-melanoma skin cancer, cervical intraepithelial neoplasia (CIN), or in situ cervical ...
... in treating patients with breast cancer that has spread to ... 0 or 1+ by immunohistochemistry (IHC) and not amplified by in situ hybridization (ISH) ...
Those with stage 0 or in-situ cancers. Patients who are not in genetic testing clinical service line. Participating Mayo Clinic locations. Study statuses ...
... in situ cervical cancer, or localized prostate carcinoma; Clinically significant vitamin B12 or folate deficiency in the 6 months before Screening; Use of any ...
Drugs used in chemotherapy, such as dexamethasone, work in different ... in-situ of the cervix or low-risk prostate cancer after curative therapy; Any ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ cold perfusion, ...
... in situ carcinomas; a secondary primary lung cancer is considered a concurrent malignancy and would make a patient ineligible for A151216; No prior treatment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.